TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014
TCL Archive In Brief: NCI May Lose Some Hard-Won New Positions For Ford’s Federal Job Cuts; Ask $9898.5 Million For Fiscal 1976 October 25, 1974
TCL Archive In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office July 20, 1990
